Health News (Reuters)

Sienna Biopharma sinks after acne treatment fails two trials

Sienna Biopharmaceuticals Inc said its lead experimental acne treatment failed to meet the main goals of two pivotal trials and that the chances of it clearing a third study appeared weaker, sending its shares tumbling 19 percent.

Sienna Biopharma sinks after acne drug fails two trials

Sienna Biopharmaceuticals Inc said on Monday two pivotal trials testing its lead experimental treatment for acne did not meet their main goals, sending its shares tumbling nearly 28 percent before the bell.

High caliber guns more deadly

(Reuters Health) - Shots from high caliber firearms are more likely to kill, a new study suggests.

Patients not bothered by doctors' body art

(Reuters Health) - Patients don't see a difference in competence, professionalism or trustworthiness when doctors sport tattoos or piercings, a small U.S. study suggests.

GSK to shut Bangladesh drug making factory by end-2018

GlaxoSmithKline will shut its drug manufacturing operations in Bangladesh by the end of this year and will continue with its healthcare business, the managing director of its local businesses said on Friday.

Pages